Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18666 | 475 | 45.7 | 65% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LYMPHOCYTIC CHORIOMENINGITIS VIRUS | Author keyword | 2 | 13% | 4% | 17 |
2 | VIRUS INDUCED MENINGITIS | Author keyword | 1 | 100% | 0% | 2 |
3 | CNRSESA 7087 | Address | 1 | 50% | 0% | 1 |
4 | ENHANCED IMMUNOPATHOLOGY | Author keyword | 1 | 50% | 0% | 1 |
5 | IMMUNIZATION OF MICE | Author keyword | 1 | 50% | 0% | 1 |
6 | MOL CH ERONES RADIOL CANC VIROL | Address | 1 | 50% | 0% | 1 |
7 | SPLENIC MORPHOLOGY | Author keyword | 1 | 50% | 0% | 1 |
8 | VIRUS DOSE | Author keyword | 1 | 50% | 0% | 1 |
9 | VIRUS INDUCED INFLAMMATION | Author keyword | 1 | 50% | 0% | 1 |
10 | VIRUS SELECTION | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INFLAMMATORY PROCESS | 5 | 22% | 4% | 21 |
2 | FOOTPAD SWELLING REACTION | 3 | 43% | 1% | 6 |
3 | MEDIATED IMMUNOPATHOLOGY | 2 | 38% | 1% | 5 |
4 | H 2D COMPATIBLE INTERACTIONS | 2 | 67% | 0% | 2 |
5 | ANTIVIRAL PROTECTION | 2 | 14% | 3% | 13 |
6 | ACUTE VIRUS INFECTION | 2 | 31% | 1% | 5 |
7 | THYMUS DERIVED LYMPHOCYTES | 2 | 24% | 1% | 6 |
8 | EFFECTOR FUNCTIONS INVIVO | 1 | 100% | 0% | 2 |
9 | BETA 2 MICROGLOBULIN DEFICIENT MICE | 1 | 14% | 2% | 9 |
10 | LYT 2 LYMPHOCYTES | 1 | 33% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Antiviral antibody responses: the two extremes of a wide spectrum | 2006 | 127 | 122 | 26% |
DISSECTION OF AN INFLAMMATORY PROCESS INDUCED BY CD8+ T-CELLS | 1990 | 142 | 31 | 81% |
Immunological memory not equal protective immunity | 2012 | 10 | 54 | 28% |
On natural and artificial vaccinations | 2003 | 170 | 89 | 13% |
ROLES OF ALPHA-BETA AND GAMMA-DELTA T-CELL SUBSETS IN VIRAL IMMUNITY | 1992 | 313 | 126 | 18% |
Lymphocytic Choriomeningitis Virus-Induced Central Nervous System Disease: a Model for Studying the Role of Chemokines in Regulating the Acute Antiviral CD8(+) T-Cell Response in an Immune-Privileged Organ | 2009 | 7 | 68 | 34% |
Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses | 1996 | 130 | 40 | 20% |
General and specific immunosuppression caused by antiviral T-cell responses | 1999 | 23 | 64 | 31% |
NATURE OF THE INFLAMMATORY PROCESS IN THE CENTRAL-NERVOUS-SYSTEM OF MICE INFECTED WITH LYMPHOCYTIC CHORIOMENINGITIS VIRUS | 1987 | 36 | 15 | 73% |
T-cell-independent antiviral antibody responses | 1998 | 54 | 35 | 17% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CNRSESA 7087 | 1 | 50% | 0.2% | 1 |
2 | MOL CH ERONES RADIOL CANC VIROL | 1 | 50% | 0.2% | 1 |
3 | VIROL EXPT | 0 | 33% | 0.2% | 1 |
4 | IMMUNOL 332 N LAUDERDALE | 0 | 17% | 0.4% | 2 |
5 | UNITE CARCINOGENESE HEPAT VIROL MOL | 0 | 25% | 0.2% | 1 |
6 | WHO ABORATING NEONATAL VACCINOL | 0 | 13% | 0.4% | 2 |
7 | UNIDAD INVEST MED IMMUNOQUIM | 0 | 20% | 0.2% | 1 |
8 | VIRAL MOLEC PATHOGENESIS | 0 | 20% | 0.2% | 1 |
9 | IMMUNOPATHOL CELLULAIRE MALAD INFECT | 0 | 14% | 0.2% | 1 |
10 | UMR S959 | 0 | 14% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000273175 | ARENAVIRUS//JUNIN VIRUS//ARENAVIRIDAE |
2 | 0.0000161876 | INTERDISCIPLINARY PROGRAM IMMUNOL//INTEGRATED IMMUNOL VACCINE//T CELL COMPETITION |
3 | 0.0000097719 | LACTATE DEHYDROGENASE ELEVATING VIRUS//UNIT EXPT MED//BIOLOGICAL EFFECTS OF MAGNETIC FIELD |
4 | 0.0000093002 | TL 2 RESPONSE//ADCC REACTION//ANTI IG DEXTRAN |
5 | 0.0000075662 | HLA A2 GENE//NONCLASSICAL MHC I//DRUG DESIGN DEV GRP |
6 | 0.0000071952 | ALLOANTIGEN SPECIFIC CYTOTOXIC T LYMPHOCYTES//ALPHA BETA TCR TRANSGENE//FOOTPAD IMMUNIZATION |
7 | 0.0000066470 | MURINE CYTOMEGALOVIRUS//MCMV//LY49H |
8 | 0.0000064472 | AS03//UNIVERSAL VACCINE//HETEROSUBTYPIC IMMUNITY |
9 | 0.0000058361 | MEMORY B CELL//GERMINAL CENTER//B CELL MIGRATION |
10 | 0.0000055148 | HGP 30//VACCINE DEV BRANCH//HIV 1 IMMUNOGEN |